Contraband medicines in Belize: import permits, seizures and GLP-1s

Medicines do not always enter Belize through the front door. In July 2026 the San Pedro Sun summarised PAHO's view that the country faces a higher risk from counterfeit or substandard medicines crossing borders¹³. The record of the Ministry of Health and Wellness and Customs shows what that looks like in practice: unpermitted cargo on a rural road, mislabelled shipments at the port, and products sold by street vendors. For physicians the pattern matters most for high-demand injectables such as semaglutide and tirzepatide, whose falsified versions WHO alerts and European safety data have documented¹⁰¹⁴.

The Orange Walk seizure

In late March 2023 Customs officials stopped a Chevrolet Silverado pickup on the San Antonio Road in Orange Walk¹. Inside were two occupants and more than two dozen boxes of medicines brought into the country without permits, valued at a little over $320,000; the boxes were confiscated and the couple detained¹. Health and Wellness Minister Kevin Bernard said he had ordered that the case be pursued fully under the law and that political affiliation would shield no one: "You are talking about people's lives – not livelihood, but life"¹. We could not find a published court outcome.

Paper that does not match the product

Illegal entry is not limited to back roads. In 2018 the Ministry denied import approval to an importer's shipment after the invoice named a supplier in England while the port of loading was Ankara, Turkey². At inspection, "all product labels and patient leaflet information were in Turkish," and the product names, manufacturer, batch numbers and expiry dates had changed from what was documented; the shipment held more units than invoiced and came with an undeclared product invoice². The Ministry also stated that "NO pharmaceutical company has been authorized to re-label or re-package" non-compliant products². Since 2016 importers of pharmaceuticals and herbal preparations have had to be licensed by the Ministry's Licensing and Accreditation Unit, and the then Director of Health Services said: "If there is a new product that is not in our database we will simply say no to it"³. That database is how inspectors judge origin: of the falsified Tylenol found in 2023, Chief Drug Inspector Dr. Crystal Samouge said, "We have not seen this batch in our importation database, so it likely means then that it came in illegally"⁷.

Street vendors and unauthorized products

In 2019 the Ministry warned that two recent inspections had led to "the identification and subsequent confiscation" of products sold as medicines by peddlers and street vendors, and stated that "peddling of medicines is illegal"⁴⁵. Such products "may be falsified, substandard and/or unregistered medicines that are sold by non-professionals," it said, urging the public to "visit only licensed pharmacies that have registered pharmacists"⁴. In 2017 inspectors found an unauthorized vitamin syrup in pharmacies, mostly in the Cayo and Belize districts; the Ministry said "We believe that the quality may be compromised" and that sellers could be charged⁶.

What the law allows inspectors to do

The Food and Drugs (Registration, Licensing and Inspection) Regulations, 2017 make it an offence to commercialize any drug without registration and a product licence, with a fine of up to $10,000⁸. Drugs for rare diseases may enter without registration, but only with written import authorization from the competent authority; importing them without it carries the same maximum fine⁸. The competent authority may "seize, confiscate or destroy any unregistered drug," and inspectors may open any package they reasonably believe contains drugs and seize any drug they believe contravenes the Act or the regulations⁸. Since 2026 Belize also reports to the WHO global drug-monitoring database, which PAHO says should help it respond faster to medicine safety concerns¹³.

Why GLP-1 drugs fit the pattern

Every route above suits GLP-1 products: they are expensive, in demand and small enough to carry. WHO issued an alert in June 2024 on falsified Ozempic batches detected in Brazil, the United Kingdom and the United States, noting that the product "was supplied in the regulated supply chain"¹⁰. PAHO warned in March 2026 of GLP-1 sales "through unofficial channels, including the internet and social media"⁹. In test purchases from illegal online pharmacies, semaglutide purity was 7.7 % to 14.37 % against the 99 % on the label, and every sample contained endotoxin¹¹. Of 234 European safety reports linked to counterfeit semaglutide, 89.3 % of suspected reactions were serious, with hypoglycaemia reported disproportionately often¹⁴; one patient was admitted in hypoglycaemic coma after a vial sold as semaglutide turned out to contain insulin¹². WHO notes that substandard and falsified products "are often sold online or in informal markets"¹⁵.